New Joint Action to Reduce the Burden of Cardiovascular Disease and Diabetes

European CommissionNon-communicable diseases such as cardiovascular diseases and diabetes pose significant health challenges and are amongst the leading causes of mortality in the EU. A new Joint Action on CARdiovascular diseases and DIabetes in Europe (JACARDI), funded by the EU4Health programme with an unprecedented EUR 53 million, kicked off this week to support 21 countries to reduce the burden of these two non-communicable diseases (NCDs).

The initiative is set to deploy 142 pilot projects across Europe, covering the entire patient journey: from improving health literacy and awareness, enhancing screening and primary prevention among high-risk populations, reaching out to people living with cardiovascular diseases and diabetes as well as their care providers and improving service pathways, self-management and labour participation. JACARDI will also address transversal and intersectional aspects, e.g., promoting equity in health, social, cultural, and ethnic diversity, and the improvement of data availability.

Background information

Around two-thirds of premature deaths in the World Health Organization European Region – are caused by four major NCDs: cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. Behavioural and biological risk factors are at the root of 85% of this burden. With the Healthier Together – EU non-communicable diseases initiative, the Commission recognises the importance of a comprehensive, strategic approach to preventing NCDs.

Useful links:

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...